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Abstract
One-third of the world population (approximately 2 billion individuals) is currently infected withMycobacterium tuberculosis, the vast
majority harboring a latent infection. As the risk of reactivation is around 10% in a lifetime, it follows that 200 million of these will
eventually develop active pulmonary disease. Only therapeutic or post-exposure interventions can tame this vast reservoir of infection.
Treatment of latent infections can reduce the risk of reactivation, and there is accumulating evidence that combination with post-
exposure vaccines can reduce the risk of reinfection. Here we develop mathematical models to explore the potential of these post-
exposure interventions to control tuberculosis on a global scale. Intensive programs targeting recent infections appear generally effective,
but the beneﬁt is potentially greater in intermediate prevalence scenarios. Extending these strategies to longer-term persistent infections
appears more beneﬁcial where prevalence is low. Finally, we consider that susceptibility to reinfection is altered by therapy, and explore
its epidemiological consequences. When we assume that therapy reduces susceptibility to subsequent reinfection, catastrophic dynamics
are observed. Thus, a bipolar outcome is obtained, where either small or large reductions in prevalence levels result, depending on the
rate of detection and treatment of latent infections. By contrast, increased susceptibility after therapy may induce an increase in disease
prevalence and does not lead to catastrophic dynamics. These potential outcomes are silent unless a widespread intervention is
implemented.
r 2007 Elsevier Ltd. All rights reserved.
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R1. Introduction
Mycobacterium tuberculosis is transmitted by airborne
particles and tuberculosis (TB) infection results when the
mycobacterium is deposited in the lungs of exposed
persons. The infection is maintained in a latent form for
a variable length of time. A small proportion of persons
progress to active TB and become infectious within the ﬁrst
years of infection, while the remainder maintains a latent
infection. Latent infections are asymptomatic and do not69
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l. (2007), doi:10.1016/j.jtbi.2007.06.005contribute to transmission, but may progress to active TB
through either endogenous reactivation or exogenous
reinfection (Small and Fujiwara, 2001; Styblo, 1978). The
relative importance of these two mechanisms is subject to a
long and intensive debate, but there is increasing consensus
that it depends on the epidemiological context (Chiang and
Riley, 2005; Gomes et al., 2004a; Vynnycky and Fine,
1997).
Three types of medical interventions are available to
address TB: treatment to cure active TB; vaccination to
prevent infection; treatment of latent TB to prevent
endogenous reactivation. While it is generally agreed that
continued attention should be given to the treatment of
active TB cases, there is no consensus about the use of73
al immunity on the prospects for tuberculosis control by post-exposure....
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Fig. 1. Model for TB transmission with treatment of latent infections or a
prophylactic vaccine. The parameters are described in Table 1.
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preventive measures. The bacille Calmette-Gue´rin (BCG) is
the only vaccine in current use against TB, and its
limitations are well recognized (Bloom and Fine, 1994).
Preventive therapy is normally restricted to individuals
with TB–HIV co-infection and contacts of tuberculosis
patients. This control measure has 60–80% efﬁcacy, and
yet its impact on mortality and transmission in low- and
middle-income countries is low, as compared to other
available interventions (Borgdorff et al., 2002). Treatment
of latent infections is not extended to the entire latent
population because it requires that large doses of
antibiotics are taken for long periods of time, which is
costly and difﬁcult to achieve (Bloom and McKinney,
1999). These caveats have motivated research into the
development of therapeutic vaccines that could block
reactivation and simultaneously reduce the risk of reinfec-
tion (Andries et al., 2005; Ha et al., 2003, 2005; Lowrie et
al., 1999; Malowany et al., 2006; McShane et al., 2004).
Here, we analyze different scenarios for post-exposure
interventions by way of mathematical modeling.
Previous models addressing the potential impact of pre-
and post-exposure interventions in tuberculosis dynamics
have, either totally or partly, excluded reinfection (Lietman
and Blower, 2000; Murphy et al., 2003; Ziv et al., 2001,
2004). However, recent studies show that reinfection is an
important cause of pulmonary tuberculosis in regions of
very high (van Rie et al., 1999), moderate (Caminero et al.,
2001) and low (Bandera et al., 2001) incidence. The results
presented here demonstrate that reinfection can dramati-
cally change the outcome of post-exposure interventions.
Little is known about the immune mechanisms under-
lying protection against active TB and whether the same
immune mechanisms mediate protection against both
reactivation and reinfection. It is generally recognized that
treatment of latent TB reduces the chances of reactivation.
However, it is still unknown how treatment inﬂuences
reinfection. Therefore, results will be presented for the
three basic scenarios: (i) treatment of latent TB does not
affect the risk of developing active TB upon reinfection; (ii)
treatment reduces susceptibility to reinfection and (iii)
treatment increases susceptibility to reinfection.
2. Model description
A mathematical model is posed, based on the assump-
tion that all individuals are equally susceptible at birth and
differentiate as they experience infection and in its case
therapy. We specify ﬁve categories for the proportions of
the population being: (S) susceptible, who have never
encountered the mycobacterium; (L1) early latent, repre-
senting individuals that were recently infected (typically
within less than two years) and have not yet developed
active TB; (I) infected, who have active TB and are
infectious; (L2) persistent latent, representing individuals
who were infected and remain latent; (R) recovered
individuals who were previously infected and treated. As
individuals experience infection, immunity and therapy, thePlease cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005ED
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proportions of the population in each category change, as
represented by the diagram in Fig. 1 and described by the
system of equations:
dS
dt
¼ m LS  mS,
dL1
dt
¼ LðS þ sL2 þ sRRÞ  ðdþ t1 þ mÞL1,
dI
dt
¼ fdL1 þ oL2 þ oRR ðt0 þ mÞI ,
dL2
dt
¼ ð1 fÞdL1  sLL2  ðoþ t2 þ mÞL2,
dR
dt
¼ t0I þ t1L1 þ t2L2  sRLR ðoR þ mÞR. ð1Þ
The parameters and their values used throughout the
paper are described in Table 1. It should be noted that the
state variables are written as fractions of the total
population which is assumed to be constant, i.e. the rate
of birth and death, m, are equal (corresponding to a mean
life time of 70 years) and there are no disease-related
deaths. As we will point out in Discussion, the results
presented here do not depend on these assumptions and are
robust against different model formulations. Individuals in
the early latent compartment L1 can progress either to
active disease (I) with rate fd or to a persistent latent
infection (L2) with rate (1f)d, following the approach in
Ziv et al. (2001). Parameter f reﬂects that only 5% of
infected individuals will ever develop active TB (Styblo,
1978; Small and Fujiwara, 2001). We choose d such that
the progression rate from early infections to active disease
is fd ¼ 0.6 yr1, which roughly approximates the data by
Styblo (1978) describing the proportions of disease devel-
opment after conversion. For the rates of reactivation we
adopt o ¼ 0.0002 yr1 for untreated latent infections
(Sutherland et al., 1982; Vynnycky and Fine, 1997) and
oR ¼ 0.00002 yr1 for those who have undergone a
therapeutic intervention. As in Gomes et al. (2004a), the
partial susceptibility factor affecting the rate of exogenousal immunity on the prospects for tuberculosis control by post-exposure....
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Table 1
Model parameters
Symbol Deﬁnition Value
b Transmission coefﬁcient Variable
m Death rate and birth rate 1/70 yr1
d Rate at which individuals leave L1 compartment 12 yr
1
f Proportion of individuals going to compartment I 0.05
o Rate of endogenous reactivation for persistent latent infections 0.0002 yr1
oR Rate of endogenous reactivation for treated individuals 0.00002 yr
1
s Factor reducing the risk of infection as a result of acquired immunity to a previous infection for persistent
latent individuals
0.25
sR Factor reducing the risk of infection as a result of acquired immunity to a previous infection for treated
individuals
Variable
t0 Rate of recovery under treatment of active TB 2 yr
1
t1 Rate of recovery of early latent individuals under post-exposure interventions Variable
t2 Rate of recovery of persistent latent individuals under post-exposure interventions Variable
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reinfection of untreated individuals, s, is ﬁxed at 0.25, in
accordance to the highest estimates of protection conferred
by BCG vaccination (Bloom and Fine, 1994). In treated
patients this factor becomes sR, for which several
exploratory values are adopted.
Treatment of different infection stages is implemented at
speciﬁc rates: t0 applies to active TB and represents the rate
of recovery (typically as a result of treatment, though here
it also accounts for the infrequent natural recovery); t1 and
t2 apply, respectively, to the latent classes L1 and L2 as the
rates at which chemotherapy or a post-exposure vaccine is
applied. The rate t0 is ﬁxed at 2 yr
1, corresponding to an
average duration of infectiousness of 6 months, while t1
and t2 are considered at different exploratory values. For
the rate of infection of susceptible individuals, we make the
usual assumption that this is proportional to the fraction of
infectious individuals, L ¼ bI. The constant of proportion-
ality b is the transmission coefﬁcient, and takes a range of
values.
The basic reproduction number (Anderson and May,
1991) R0, is proportional to the transmission coefﬁcient, b.
The relationship between the two was obtained using the
approach in van den Driessche and Watmough (2002):
R0 ¼
dðoþ fmÞðoR þ mÞ
mðoR þ t0 þ mÞðdþ mÞðoþ mÞ
b. (2)
The endemic threshold (ET) at R0 ¼ 1 indicates the
minimal transmission potential that sustains endemic
disease. The model accommodates other thresholds in
transmission, namely reinfection thresholds that are central
to the results presented here. The description and calcula-
tion of the endemic threshold and the reinfection threshold
(RT) are in the Appendix A.
3. Interventions that reduce reactivation
The ﬁrst set of results concerns an exploration of
different target subpopulations for the treatment of latent
infection when the intervention does not alter the risk ofPlease cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005D P
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OFreinfection. Fig. 2(a) represents the proportion of active TBindividuals at equilibrium in model populations ranked bythe transmission coefﬁcient, b. The heavy line provides
baseline information: it shows the proportion of indivi-
duals with active TB before treatment of latent infections is
implemented (t0 ¼ 2 and t1 ¼ t2 ¼ 0). It reveals persistence
of infection above the endemic threshold (ET: R0 ¼ 1)
(Anderson and May, 1991) and a steep rise in prevalence
above the RT (RT: R0E1/s, as described in the Appendix
A). The thinner lines show new equilibria under different
strategies for treatment of latent TB. Early detection and
treatment is implemented in the same fashion for all cases
(t0 ¼ 2 and t1 ¼ 1). The dashed lines represent the
minimum and maximum effect of treating persistent latent
infections, where no treatment (t2 ¼ 0), and immediate
treatment (t2-N), respectively, gives the upper and lower
bounds. For illustration, the full line corresponds to a
moderate treatment rate of persistent latent infections
(t2 ¼ 0.1). Fig. 2(b) shows the proportional reduction that
each intervention has on TB prevalence. Above the RT, the
reduction fades out.
4. Interventions that alter reinfection
The second set of results emerges from relaxing the strict
assumption that latent and recovered (treated) individuals
have the same reinfection risk. Figs. 3 and 4 describe the
results of differentiating the risks of reinfection of these
two classes. Fig. 3 is obtained for illustration of the driving
mechanisms, by neglecting reactivation (o ¼ oR ¼ 0). This
simpler context provides deeper insight, revealing the
central role of reinfection on post-exposure intervention
outcomes. Fig. 4 demonstrates that qualitatively equivalent
results are obtained when reactivation is incorporated into
the model.
Fig. 3(b) shows the prevalence of active TB in
equilibrium without reactivation of persistent infections,
and marks the position of the endemic (R0 ¼ 1) and
reinfection (R0 ¼ 1/s) thresholds on the transmissibilityal immunity on the prospects for tuberculosis control by post-exposure....
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Fig. 3. Illustration of how the proportion of active TB individuals changes
if the susceptibility to reinfection of treated individuals differs from that of
latents: (a)sRos; (b) sR ¼ s; (c) sR4s. The heavy lines represent baseline
equilibria, and the thinner lines show the proportions of active TB
individuals under different treatment programs. Treatment of recent
converters (L1) is implemented at a ﬁxed rate (t1 ¼ 1), and treatment of
persistent latent infections (L2) is implemented at the indicated rates (t2).
The plots show equilibrium proportions of active TB under the simplifying
assumption that reactivations do not occur, o ¼ oR ¼ 0.
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Fig. 2. Treatment of latent TB infection when treatment reduces
reactivation rates and does not alter reinfection rates. (a) The heavy line
represents the baseline proportion of active TB individuals (t1 ¼ t2 ¼ 0)
and the thinner lines show lower proportions due to the implementing
treatment of recent latent infections at a ﬁxed rate (t1 ¼ 0) in combination
with treatment of persistent latent infections at three distinct rates: the two
extremes (t2 ¼ 0, t2-N) in dashed lines; and an intermediate rate
(t2 ¼ 0.1) in solid line. (b) Proportional reduction in prevalence attributed
to the two treatment programs. The epidemic threshold (R0 ¼ 1) and the
reinfection threshold (R0E1/s) are marked as ET and RT, respectively.
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Raxis (b). This plot is equivalent to Fig. 2(a) with
o ¼ oR ¼ 0. Two possible scenarios for the way treatment
changes the risk of exogenous reinfection are explored in
Figs. 3(a), (c): (a) susceptibility decreases after treatment
(sRos); (c) susceptibility increases after treatment (sRos).
In the absence of treatment of latent infection
(t1 ¼ t2 ¼ 0), the equilibrium proportion of the population
that has active TB (heavy lines) is similar for all three
scenarios. However, notable differences emerge when
widespread treatment of latent infections is implemented
(thin lines). As before, early detection and treatment is
equally implemented in all cases (t1 ¼ 1), and the dashed
lines illustrate the limiting cases of extending the interven-
tion to persistent infections (t2 ¼ 0 and t2-N). The
differentiation of reinfection risks (sR 6¼s) unfolds the RT
into two distinct transmissibility values: R0 ¼ 1/s, in
association with reinfection of individuals in the latentPlease cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005class (L2); and R0 ¼ 1/sR, in association with reinfection of
individuals in the treated class (R). These transmission
rates bound the parameter region where post-exposure
treatment regimes have most impact. An important ﬁnding
is that the two boundaries appear in reverse order whenal immunity on the prospects for tuberculosis control by post-exposure....
E
 PR
OO
F
ARTICLE IN PRESS
YJTBI : 4751
1
3
5
7
9
11
13
15
17
19
21
23
25
27
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
87
89
91
93
95
97
99
101
103
105
107
109
111
113
10−5
10−4
10−3
10−2
10−1
100
A
p
ro
p
o
rt
io
n
 w
it
h
 a
c
ti
v
e
 T
B σR = σ/ 2 
τ2 = 0
τ2 = 0.5
τ2 = 1
 E
T
R
T
R
T
R
τ2 → ∞
0 50 100 150 200 250 300 350 400
10−5
10−4
10−3
10−2
10−1
100
B
transmission coefficient, β
p
ro
p
o
rt
io
n
 w
it
h
 a
c
ti
v
e
 T
B
σR = 2 σ
τ2 = 0.5
τ2 = 0
E
T
R
T
R
T
R
σR =  σ / 2
τ2 = 0.5
τ2 = 0.6
τ2 = 0
τ2 → ∞
0 20 40 60 80 100
time (in years)
σR = 2 σ
τ2 = 1
τ2 = 0.1
τ2 = 0
τ2 → ∞
τ2 → ∞
Fig. 4. Illustration of how the proportion of active TB individuals changes if the susceptibility of treated individuals differs from that of latents: (a, c) show
equilibrium proportions of active TB; (b, d) show simulations following the proportion of active TB individuals over time since the introduction of
treatment of latent infections. The heavy lines represent baseline equilibria, and the thinner lines show the proportions of active TB individuals under
different treatment programs. Treatment of recent converters (L1) is implemented at a ﬁxed rate (t1 ¼ 1), and treatment of persistent latent infections (L2)
is implemented at a series of rates (t2 ¼ 0; 01; 0.2;y; 1; and the limit t2-N). Epidemic and reinfection thresholds are marked by ET, RT and RTR.
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sRos (Fig. 3(a)) and sR4s (Fig. 3(c)). As detailed next,
boundary order underlies dynamic changes that have
crucial implications for public health.
The outcome of treating latent TB at a moderate rate lies
between the two incidence levels observed at the upper and
lower transmission boundaries described above. However,
the relative magnitude of s and sR determines whether the
intervention will cause a reduction or an increase in the
prevalence of active TB. The intermediate outcomes are
illustrated by considering the effect of t2 ¼ 0.5 in the two
possible scenarios. In the ﬁrst scenario (sRos), the
intervention is always beneﬁcial, as the treated class
increases the effective reinfection threshold. The prevalence
of active TB decreases due to the reduction in susceptibility
to reinfection. Moreover, the thin lines now reveal an S-
shaped form in the relation between transmission and
prevalence of active TB (Fig. 3(a)), accommodating
bistable equilibria with basins of attraction that are
separated by an unstable equilibrium (dotted segment).
The intervention outcome is remarkably different if
susceptibility to reinfection increases after treatment
(sR4s). In this case, there is a range of transmissibilities
where the thin lines lie above the heavy line, implying an
increase in active TB prevalence in the population due to
the implementation of widespread treatment of persistent
latent TB. This occurs because the RT associated with the
treated class is lower.Please cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005D5. Interventions that alter reactivation and reinfection
Here we review the analyses when reactivation is
included in the model. Expressions for the corresponding
reinfection thresholds are given by equalities (A.4) and
(A.6) in the Appendix A, but are approximated by R0 ¼ 1/
s and R0 ¼ 1/sR when o and oR are small (here,
o ¼ 0.0002 and oR ¼ 0.00002). Precise threshold values,
marked RT and RTR, appear in Figs. 4(a), (c), in plots
qualitatively equivalent to Figs. 3(a), (c). Figs. 4(b), (d),
trace model dynamics in time upon intervention imple-
mentation over a range of rates t2, illustrating the bistable
behavior associated with the S-shaped curves in Figs. 3(a)
and 4(a).
We use initial conditions corresponding to the endemic
infectious level marked by point A in Fig. 4(a) to show how
intervention efforts modify model dynamics under the ﬁrst
scenario (sRos). Fig. 4(b) shows the prevalence of active
TB over time upon introducing treatment of latent
infection at rates t2 ¼ 0.1, 0.2,y,1.0. Dashed lines mark
the limiting cases, t2 ¼ 0 and t2-N. A critical treatment
rate of t20.5 separates policies of contrasting success. The
reduction in prevalence is small to moderate for t2p0.5
(sub-critical intervention) and very large for t2X0.6 (super-
critical intervention). Bistable dynamics have been de-
scribed previously for hepatitis-B (Medley et al. 2001), in
host–parasite interactions (May, 1977) and in various
ecosystems (Scheffer et al., 2001). The potential foral immunity on the prospects for tuberculosis control by post-exposure....
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Fig. 5. Consequences of post-exposure treatment summarized in a two-
parameter diagram. The shaded regions mark the new model behavior
when widespread treatment is implemented at the rates t1 ¼ 1, t2 ¼ 0.5:
bistability (marked A); increased prevalence (marked B) and illustrated by
scenarios A and B, respectively, in Fig. 4.
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dramatic changes characteristic of bistability must be taken
into account when evaluating both conservation and
eradication strategies.
To simulate the second scenario (sR4s) we use model
population B (marked in Fig. 4(c)). The associated
dynamics are represented in Fig. 4(d). In this case, the
order of two reinfection thresholds does not lead to
bistability, but widespread treatment of latent infection
leads to an increase in prevalence of active TB for a range
of transmissibilities. Whether the effect of the intervention
is positive or negative depends on the balance between the
decreased risk of endogenous reactivation and the in-
creased risk of exogenous reinfection (Fig. 4(c)).
Fig. 5 provides a summary of the behavior attributed to
differences in susceptibility to reinfection between persis-
tent latent and recovered individuals. The horizontal line at
zero corresponds to no difference in susceptibility (sR ¼ s).
Above the line, recovered individuals are less susceptible
(sRos) and bistability occurs in the shaded area (marked
A) with the typical shape of a cusp catastrophe (Zeeman,
1977). Below the line, recovered individuals are more
susceptible (sR4s) and the shaded area (marked B)
indicates the region where widespread treatment of latent
TB leads to an increase in disease prevalence. These effects
are triggered by a widespread post-exposure intervention.
6. Bistability and catastrophic dynamics
The interplay between population compartments with
different susceptibility status is what gives rise to bist-
ability: a factor s modiﬁes susceptibility of individuals who
harbor untreated persistent latent infections (L2); and a
different factor sR affects susceptibility of those who have
been treated (R). In the absence of treatment of persistent
latent infection (t2 ¼ 0) the prevalence of active TB at
equilibrium undergoes a steep increase at the RT. APlease cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005ED
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widespread strategy of treatment of latent infection (high
t2) has the potential to bring the endemic equilibrium to a
curve whose RT is RTR. Intervention impact can be
unexpectedly high for populations whose transmissibility
lies between RT and RTR. When RTR is greater than RT
(i.e. sRos) this potential represents dramatic beneﬁts to
TB control, but whether it will be made real depends
critically on intervention design.
The dynamics exhibited here include two alternative
ways out of L2 with opposite effects on the prevalence of
disease: natural progression of infection increases the
incidence of active TB (via reactivation or reinfection,
o+sbI); and human interventions are designed to reduce
the incidence of active TB (via treatment, t2). As such,
natural processes and medical interventions can be seen as
competing for individuals in L2. The bistable outcome of
the intervention is explained by noting that the ﬁrst process
increases with the prevalence of active TB, while the second
is constant. It is therefore not surprising that a threshold in
the prevalence of active TB dictates whether the interven-
tion ‘‘wins’’ or ‘‘loses’’ over natural progression. While the
prevalence of active TB remains above this threshold,
natural processes causing disease are the winners and the
intervention has little impact. If the prevalence drops below
the threshold, the intervention wins and succeeds in
bringing active TB close to the lower equilibrium curve.
Fig. 4(b) reﬂects this phenomenon at intermediate rates of
treatment of latent TB. Initially, treatment of latent
infections induces only a slow decrease in the prevalence
of active TB. Large numbers of untreated latent individuals
reacquire infection at the relatively fast rate sbI, thus
slowing down disease control. However, once treatment
reduces availability of persistent latent individuals below a
threshold (at the unstable equilibrium), a more rapid
decrease in the prevalence of active TB follows. From this
point onwards, most reinfections occur in treated indivi-
duals at a comparatively lower rate sRbI. This change in
behavior can be explored in the interest of control by
appropriately varying the treatment rate during the course
of the intervention.
7. Consequences to intervention design
Fig. 6 illustrates the potential of interventions that are
implemented at high rates during an initial phase, relaxing
them later to lower rates. Starting from equilibrium A (as
in Fig. 4(a)), alternative intervention strategies are initiated
at time t ¼ 0. The duration of the initial phase is critical to
intervention outcome: the higher line traces the time course
of active TB if t2 ¼ 1 is maintained for 13 years, and the
lower line shows the result of extending this initial (more
intense) phase to 14 years. In both cases, the intervention is
then relaxed to t2 ¼ 0.5. Contrasting prevalence levels
result, demonstrating the way in which similar public
health measures can have radically different long-term
effects on disease control owing to bistability. This
sensitivity is a characteristic of catastrophic dynamicsal immunity on the prospects for tuberculosis control by post-exposure....
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Fig. 6. Simulations following the proportion of active TB individuals over
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from the higher to the lower equilibrium branch occurs when the higher
treatment rate t2 ¼ 1 is prolonged between 13 and 14 years.
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health. Similar bistable dynamics have also been predicted
by previous TB models (Feng et al., 2000; Singer and
Kirschner, 2004), but relied on arguably unrealistic
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T8. DiscussionIn this paper, mathematical models were used to help
deﬁne target subpopulations for screening and treating
latent TB infections, and to explore the potential of
widespread post-exposure interventions such as chemother-
apy or post-exposure vaccination. The primary require-
ment for such medical interventions is the capacity to
reduce the risk of reactivation of latent infections. Since the
risk of progression to active TB is especially high during
the initial years following infection, recent converters
should deﬁnitely be treated. As for the adoption of more
widespread interventions, our results are more elaborate,
and depend critically on whether the intervention decreases
or increases susceptibility to reinfection. Given the lack of
published studies providing direct evidence for either
assumption, we explored both possibilities and described
their public health implications. Indeed, on the one hand
one could argue that latent infection helps to sustain
immunity to tuberculosis. In this case, treatment would
increase the risk that subsequent infection leads to active
TB. On the other hand, the risk of reactivation may be
higher in untreated hosts, who harbor larger amounts of
bacteria than those treated. Reinfection may then trigger
reactivation of a latent infection (Warren et al., 2004),
which suggests that treatment would reduce the risk of
reinfection.Please cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005D P
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OF
According to our model, the scenario where treatment
reduces the risk of reinfection gives rise to conditions of
bistability: the impact of the intervention depends critically
on whether the treatment rate is above or below a
threshold. If the treatment rate is increased across this
critical value, the resulting reductions in TB-prevalence in
regions of high burden of disease go up by one or two
orders of magnitude. As is typical for such catastrophic
dynamics, the existence of bistability is unapparent and has
no ‘‘early-warning signals’’ until a tiny change in treatment
rate triggers a large shift from one dynamical regime to the
other (Zeeman, 1977).
If, on the contrary, treatment increases the risk of
reinfection, it will be of limited beneﬁt. Success depends
then on the balance between decreasing reactivation and
increasing reinfection rates, which likely will vary among
populations.
These contrasting results evidence how reinfection may
fundamentally affect control strategies, and underscore the
need to understand the host–pathogen interaction mechan-
isms that determine reinfection risk in M. tuberculosis.
Epidemiologic study designs with the capacity to separately
estimate the impact of post-exposure interventions on
reactivation and reinfection would therefore be decisive.
The qualitative effects presented in this paper are
generally robust against reasonable changes in parameter
values and model assumptions. The results persist the
inclusion of TB-related death rates and varying population
size as well as the implementation of different demo-
graphics (with constant recruitments and linear death
terms as in Murphy et al., 2002, 2003) and a wide range of
reactivation rates (these results will be presented else-
where). In fact, reactivation parameters o and oR were set
to zero in Section 4 of this paper for illustration purposes,
without provoking any signiﬁcant change in the predicted
behavior. Furthermore, the transmissibility parameter b
has been abundantly explored in bifurcation diagrams, and
parameters corresponding to treatment rates, t0, t1 and t2,
being the object of study, were varied as appropriate. On
the other hand, parameter values for d and f have been
taken from well-accepted estimates in the literature and can
be varied within reasonable ranges without changing the
reported effects qualitatively. Partial susceptibility factors
s and sR, that affect reinfection rates, are crucial to
determine the position of the behavior of interest (i.e.,
reinfection thresholds) on the transmissibility axis. Increas-
ing (decreasing) one of these parameters shifts the
associated RT to the left (right) according to Eqs. (A.4)
and (A.6) in the Appendix A. Hence, the observed effects
can also occur in smaller as well as larger ranges of
transmission coefﬁcients (and, equivalently, R0).
One aspect that deserves further exploration, however, is
the sensitivity of the results on the total rate of departure
from the early latent class, d. It should be noted that the
bistable behavior reported here is observed when this rate
is larger than around 4 yr1, corresponding to an average
time of 3 months or less before an individual moves toal immunity on the prospects for tuberculosis control by post-exposure....
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persistent latent or active TB. The majority of mathema-
tical models in the TB literature, however, bypass this state
by implementing direct transitions from susceptible states
to either persistent latent or active TB, corresponding to an
inﬁnitely large d (see, for example, Blower et al. 1995; Dye
et al., 1998; Feng et al. 2000; Gomes et al. 2004a; Murphy
et al. 2002, 2003; Murray and Salomon, 1998). The implicit
representation of an early latent class has been exception-
ally implemented in few models (Aparicio et al., 2002; Ziv
et al., 2001; Vynnycky and Fine, 1997). Vynnycky and Fine
(1997) use a value of 0.5 yr1, while Ziv et al. (2001) of
1.5 yr1 and Aparicio et al. (2002) a time-dependent value
that is always larger than 1 yr1. Parameter choices can
depend critically on the context of the particular model
structure. To our knowledge, there are no data unequi-
vocally suggesting a certain parameter range. This holds in
particular for the progression rate (1fd from early (L1) to
persistent latent infections (L2), whereas we have a good
motivation for the parameter value of the rate fd from
early latent infections to active disease (I). Future exten-
sions might consider a relaxation of this latter rate.
Finally, the model presented here extends earlier models
(Blower et al., 1995; Feng et al., 2000; Gomes et al., 2004a;
Lietman and Blower, 2000; Murphy et al., 2002, 2003;
Singer and Kirschner, 2004; Ziv et al., 2001, 2004), but
tailors more complicated models (Murray and Salomon,
1998), in order to gain insight into the underlying dynamics
(Anderson, 1998). The effects presented do not rely on the
complexities of reactivation that characterize tuberculosis,
and may be applicable to other diseases where natural
infection and medical interventions alter the risk of
(re)infection upon subsequent exposures.
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Appendix A
A1. Interpretation of R0
The expression of R0, given by (2) in Section 2,
R0 ¼ dðoþ fmÞðoR þ mÞmðoR þ t0 þ mÞðdþ mÞðoþ mÞ
b
can be written as the sum of different progressions into
active TB. In the simpler case oR ¼ 0 we can write
Rn0 ¼
b
ðt0 þ mÞ
fd
ðdþ mÞ þ
ð1 fÞd
ðdþ mÞ
o
ðoþ mÞ
 
. (A.1)
The ﬁrst factor in Eq. (A.1) gives the average number of
secondary cases produced by a single individual with activePlease cite this article as: Gabriela M. Gomes, M., et al., Implications of parti
J. Theor. Biol. (2007), doi:10.1016/j.jtbi.2007.06.005TB in a completely susceptible population during its
infectious period. The ﬁrst and second terms in the second
factor reﬂect that individuals progress towards active TB
through either the early latent and persistent latent class,
respectively. When oR40, recovered individuals have an
extra opportunity to progress to active TB that does not
depend on re-exposures. This extra contribution for the
infectious period is expressed by the term
ðt0 þ mÞðoR þ mÞ
mðoR þ t0 þ mÞ
¼ 1
1 t0oR=ðt0 þ mÞðoR þ mÞ
¼ 1þ t0ðt0 þ mÞ
oR
ðoR þ mÞ
þ t0ðt0 þ mÞ
oR
ðoR þ mÞ
 2
þ . . . , ðA:2Þ
that results from the countless opportunities the infected
individual has to repeat this event. The full expression for
R0 is then the product of Eqs. (A.1) and (A.2).ED
 PR
OOA2. Calculation of the reinfection thresholdReinfection thresholds correspond to critical transmissi-bility values, above which there is a steep nonlinear
increase in disease prevalence. This is because infection
can be maintained in a population of previously infected
(and partially immune) individuals. These thresholds are
approximated using reinfection submodels that isolate
reinfection from other mechanisms (such as primary
infection and reactivation). Such submodels are obtained
by considering a population where all individuals have
been challenged previously, thus acquiring a degree of
immunity, and by assuming that reactivation is absent
(o ¼ oR ¼ 0). A bifurcation in the submodels is then
associated to an RT in the full model (Gomes et al., 2004b,
2005; Breban and Blower, 2005).
The case sR ¼ s leads to a system where the classes L2
and R are equivalent and can be merged. The reinfection
submodel supports endemic equilibria when transmission is
above the critical value
b ¼ 1
s
ðt0 þ mÞðdþ t1 þ mÞ
df
, (A.3)
hereafter called the reinfection threshold (RT). Substituting
Eq. (2) into Eq. (A.1), the RT is written in terms of R0 as
R0 ¼
1
s
dðoþ fmÞðoR þ mÞðt0 þ mÞðdþ t1 þ mÞ
dfmðoR þ t0 þ mÞðdþ mÞðoþ mÞ
. (A.4)
The simpler relation R0 ¼ 1/s (Gomes et al., 2004a, b) is
obtained for the particular case o ¼ oR ¼ 0 and no
intervention is in place (t1 ¼ 0).
For the case sR6¼s, we consider two extreme scenarios
for the treatment of persistent latent infections: t2 ¼ 0-no
treatment of persistent infections; and t2-N-idealized
instantaneous treatment.
When post-exposure measures apply only to early
detection (t2 ¼ 0), the dynamics of the full model areal immunity on the prospects for tuberculosis control by post-exposure....
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reinfection submodel can then be seen to support an
endemic equilibrium when transmission is above the
reinfection threshold (A.3).
If, on the other extreme, we consider that latent
individuals move instantaneously out of class L2 into the
recovered class R (by treatment of persistent latents at rate
t2-N), the dynamics are determined by reinfection of the
recovered class. It is therefore assumed in the reinfection
submodel, that all individuals entering the system go into
the R class, where they are subject to the factor of
protection, sR. Reinfection of recovered individuals may
then sustain an endemic equilibrium if transmission is
above the alternative reinfection threshold (RTR)
b ¼ 1
sR
ðt0 þ mÞðdþ t1 þ mÞ
df
, (A.5)
which can be written in terms of R0 as
R0 ¼
1
sR
dðoþ fmÞðoR þ mÞðt0 þ mÞðdþ t1 þ mÞ
dfmðoR þ t0 þ mÞðdþ mÞðoþ mÞ
. (A.6)
Transmission thresholds ET, RT and RTR, associated
with this model are marked as vertical dotted lines in Figs.
2–4.E
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